1. The “collateral damage” of the war on COVID-19: impact of the pandemic on the care of epithelial ovarian cancer

   • Luxitaa Goenka
   • Annuja Anandaradje
   • Prasanth Ganesan

   Short Communication 28 September 2021 Article: 137

2. Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in response to Onal’s letter to the editor

   • L. Triggiani
   • D. Tomasini
   • R. Mazzola

   Letter to the Editor 28 September 2021 Article: 136

3. Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signaling

   • Erika Heninger
   • David Kosoff
   • Joshua M. Lang

   Original Paper Open access 28 September 2021 Article: 135

   

4. Cancer induced bone pain: current management and future perspectives

   • Ruchi Kapoor
   • Ashok Kumar Saxena
   • Arvind Kumar

   Review Article 28 September 2021 Article: 134

5. Lipid droplet evolution gives insight into polyaneuploid cancer cell lipid droplet functions

   • Laurie G. Kostecka
   • Kenneth J. Pienta
   • Sarah R. Amend

   Review Article Open access 28 September 2021 Article: 133

   

6. WAC, a novel GBM tumor suppressor, induces GBM cell apoptosis and promotes autophagy

   • Yixuan Wang
   • Si Zhang
   • Baohui Liu

   Original Paper 28 September 2021 Article: 132

   

7. Apigenin increases radiosensitivity of glioma stem cells by attenuating HIF-1α-mediated glycolysis

   • Ying Zhao
   • Hui Huang
   • Mei-Lin Xie

   Original Paper 23 September 2021 Article: 131

   

8. Direct oral anticoagulants in cancer patients: which help from the specialist hemostasis and thrombosis laboratory?

   • Leonardo Di Gennaro
   • Fabio Marazzi
   • Raimondo De Cristofaro

   Letter to the Editor 23 September 2021 Article: 130

9. Effects of electroporation on anticancer activity of 5-FU and newly synthesized zinc(II) complex in chemotherapy-resistance human brain tumor cells

   • Mehmet Eşref Alkış
   • Nevin Turan
   • Kenan Buldurun

   Original Paper 22 September 2021 Article: 129

   

10. Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial

    • Yoshinori Imamura
    • Kaoru Tanaka
    • Hironobu Minami

    Original Paper 22 September 2021 Article: 128